321 related articles for article (PubMed ID: 30970005)
21. Predictors of left atrial fibrosis in patients with atrial fibrillation referred for catheter ablation.
Rossi VA; Krizanovic-Grgic I; Steffel J; Hofer D; Wolber T; Brunckhorst CB; Ruschitzka F; Duru F; Breitenstein A; Saguner AM
Cardiol J; 2022; 29(3):413-422. PubMed ID: 35285513
[TBL] [Abstract][Full Text] [Related]
22. Biomarkers in Persistent AF and Heart Failure: Impact of Catheter Ablation Compared with Rate Control.
Jones DG; Haldar SK; Donovan J; McDonagh TA; Sharma R; Hussain W; Markides V; Wong T
Pacing Clin Electrophysiol; 2016 Sep; 39(9):926-34. PubMed ID: 27436224
[TBL] [Abstract][Full Text] [Related]
23. Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis.
Njoku A; Kannabhiran M; Arora R; Reddy P; Gopinathannair R; Lakkireddy D; Dominic P
Europace; 2018 Jan; 20(1):33-42. PubMed ID: 28444307
[TBL] [Abstract][Full Text] [Related]
24. Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation.
Hwang HJ; Son JW; Nam BH; Joung B; Lee B; Kim JB; Lee MH; Jang Y; Chung N; Shim WH; Cho SY; Kim SS
Clin Res Cardiol; 2009 Apr; 98(4):213-8. PubMed ID: 19229464
[TBL] [Abstract][Full Text] [Related]
25. Are the atrial natriuretic peptides a missing link predicting low-voltage areas in atrial fibrillation? Introducing the novel biomarker-based atrial fibrillation substrate prediction (ANP) score.
Seewöster T; Büttner P; Zeynalova S; Hindricks G; Kornej J
Clin Cardiol; 2020 Jul; 43(7):762-768. PubMed ID: 32462768
[TBL] [Abstract][Full Text] [Related]
26. Prediction of electro-anatomical substrate using APPLE score and biomarkers.
Kornej J; Büttner P; Sommer P; Dagres N; Dinov B; Schumacher K; Bollmann A; Hindricks G
Europace; 2019 Jan; 21(1):54-59. PubMed ID: 29893827
[TBL] [Abstract][Full Text] [Related]
27. Impact of Midregional N-Terminal Pro-Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treated With Catheter Ablation for Atrial Fibrillation: The Biorhythm Study.
Badoz M; Serzian G; Favoulet B; Sellal JM; De Chillou C; Hammache N; Laurent G; Mebazaa A; Ecarnot F; Bardonnet K; Seronde MF; Schiele F; Meneveau N
J Am Heart Assoc; 2021 Jul; 10(13):e020917. PubMed ID: 34187182
[TBL] [Abstract][Full Text] [Related]
28. Predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide level for atrial fibrillation recurrence after radiofrequency catheter ablation.
Zhao Q; Yang W; Li X; Yao M; Guo J; Wang Y; Shan Z
Postepy Kardiol Interwencyjnej; 2023 Jun; 19(2):163-170. PubMed ID: 37465622
[TBL] [Abstract][Full Text] [Related]
29. Plasma renin activity and pro-B-type natriuretic peptide levels in different atrial fibrillation types.
Doğan A; Gedikli O; Ozaydin M; Acar G
Anadolu Kardiyol Derg; 2010 Aug; 10(4):317-22. PubMed ID: 20693126
[TBL] [Abstract][Full Text] [Related]
30. Interplay between natriuretic peptides and left atrial mechanics and the relation to recurrence of atrial fibrillation following catheter ablation.
Olsen FJ; Darkner S; Goetze JP; Chen X; Henningsen K; Pehrson S; Svendsen JH; Biering-Sørensen T
Int J Cardiovasc Imaging; 2023 Oct; 39(10):1889-1895. PubMed ID: 37428246
[TBL] [Abstract][Full Text] [Related]
31. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.
Shelton RJ; Clark AL; Goode K; Rigby AS; Cleland JG
Eur Heart J; 2006 Oct; 27(19):2353-61. PubMed ID: 16952921
[TBL] [Abstract][Full Text] [Related]
32. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status.
Kristensen SL; Mogensen UM; Jhund PS; Rørth R; Anand IS; Carson PE; Desai AS; Pitt B; Pfeffer MA; Solomon SD; Zile MR; Køber L; McMurray JJV
Circ Heart Fail; 2019 Mar; 12(3):e005766. PubMed ID: 30871349
[TBL] [Abstract][Full Text] [Related]
33. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
[TBL] [Abstract][Full Text] [Related]
34. NT-proANP levels in peripheral and cardiac circulation.
Büttner P; Seewöster T; Obradovic D; Hindricks G; Thiele H; Kornej J
J Interv Card Electrophysiol; 2022 Mar; 63(2):409-415. PubMed ID: 34173166
[TBL] [Abstract][Full Text] [Related]
35. Comparison of N-terminal pro-atrial natriuretic peptide and three cardiac biomarkers for discriminatory ability of clinical stage in dogs with myxomatous mitral valve disease.
Ogawa M; Hori Y; Kanno N; Iwasa N; Toyofuku T; Isayama N; Yoshikawa A; Akabane R; Sakatani A; Miyakawa H; Hsu HH; Miyagawa Y; Takemura N
J Vet Med Sci; 2021 Apr; 83(4):705-715. PubMed ID: 33551383
[TBL] [Abstract][Full Text] [Related]
36. Association between left atrial low-voltage area, serum apoptosis, and fibrosis biomarkers and incidence of silent cerebral events after catheter ablation of atrial fibrillation.
Müller P; Maier J; Dietrich JW; Barth S; Griese DP; Schiedat F; Szöllösi A; Halbfass P; Nentwich K; Roos M; Krug J; Schade A; Schmitt R; Mügge A; Deneke T
J Interv Card Electrophysiol; 2015 Oct; 44(1):55-62. PubMed ID: 26048130
[TBL] [Abstract][Full Text] [Related]
37. N-terminal pro-B-type natriuretic peptide level at long-term follow-up after atrial fibrillation ablation: a marker of reverse atrial remodelling and successful ablation.
Solheim E; Off MK; Hoff PI; De Bortoli A; Schuster P; Ohm OJ; Chen J
J Interv Card Electrophysiol; 2012 Aug; 34(2):129-36. PubMed ID: 21993599
[TBL] [Abstract][Full Text] [Related]
38. Relationship of Natriuretic Peptides with Left Atrial Structure and Function within 1 Month after Electrical Cardioversion in Patients with Persistent Atrial Fibrillation.
Karaliute R; Jureviciute J; Jurgaityte J; Stanaitiene G; Mizariene V; Kazakevicius T; Urboniene D; Kavoliuniene A
Biomed Res Int; 2019; 2019():7636195. PubMed ID: 31008112
[TBL] [Abstract][Full Text] [Related]
39. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M
Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312
[TBL] [Abstract][Full Text] [Related]
40. B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance.
Wozakowska-Kapłon B; Bartkowiak R; Grabowska U; Janiszewska G
Kardiol Pol; 2010 Jul; 68(7):781-6. PubMed ID: 20648436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
